Article
Comparison of Staphylococcus aureus tolerance between antimicrobial blue light, levofloxacin, and rifampin
25 May 2023
Abstract excerpt
Background Bacterial biofilms readily develop on all medical implants, including percutaneous osseointegrated (OI) implants. With the growing rate of antibiotic resistance, exploring alternative options for managing biofilm-related infections is necessary. Antimicrobial blue light (aBL) is a unique therapy that can potentially manage biofilm-related infections at the skin-implant interface of OI implants....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
